DCGI grants limited approval to market Stempeucel® product for treating Critical Limb Ischemia due to Buerger's disease Geeta Sharma Sharma4 Jun 2016 1:21 PM ISTStempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the Drugs...